The First-in-human Study of SRN-001 in Healthy Participants

Clinical trial NCT05984992 · COMPLETED

Trial details

NCT number: NCT05984992
Sponsor: siRNAgen Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-09-08
Primary completion: 2024-03-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.